Skip to main content
Premium Trial:

Request an Annual Quote

David Weavil

Acuamark Diagnostics has appointed David Weavil to its board of directors. Previously Weavil was CEO and president of Solstas Lab Partners which he founded and sold to Quest Diagnostics. Prior to that, Weavil served as CEO of Specialty Laboratories, currently owned by Quest. He also served as chairman and CEO of Unilab, and helped build Biomedical Reference Labs, currently named Roche Biomedical Labs.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.